AGN1
Live / Applied — Response to non-final action entered (as of 06 Aug 2025)
What this means for you
Not registered yet, but its 21 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98461614
- Mark type
- Stylized text
- Filed
- 21 Mar 2024
- Attorney of record
- Matthew J. Smith
Goods and services
- Class 005 — Pharmaceuticals: Bone void fillers consisting of biological materials; pharmaceutical products for treatment of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for altering bone density; medications for the prevention or treatment of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for preventing or treating of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for use in enhancing cardiovascular health and bone health
Owner
- AgNovos Healthcare USA, LLC, Rockville, MD, US
Prosecution history
- 06 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Apr 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 28 Apr 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 06 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Feb 2025 — NON-FINAL ACTION E-MAILED
- 06 Feb 2025 — NON-FINAL ACTION WRITTEN
- 28 Sept 2024 — ASSIGNED TO EXAMINER
- 17 Aug 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Mar 2024 — NEW APPLICATION ENTERED